Related Experiment Video
Updated: Jul 8, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
MELAS masquerading as a systemic vasculitis
1Wilford Hall Medical Center, Lackland AFB, TX. matthew.carroll@keesler.af.mil
Abstract:
Mitochondrial encephalomyopathy, lactic acidosis, and stroke (MELAS) is a mitochondrial genetic disorder caused by a point mutation, resulting in the substitution of guanine for adenine at nucleotide 3243 (A3243G). It is a multisystem disorder with variable manifestations and typically presents between the first and third decades of life. It should be suspected if a patient exhibits stroke-like episodes before age 40, encephalopathy characterized by seizures, dementia, or both, and lactic acidosis, ragged-red fibers in muscle, or both. We present the case of a 26-year-old white man suspected with primary central nervous system vasculitis admitted to our facility with profound constipation from severe intestinal dysmotility. Although his gastrointestinal and neurologic symptoms did not meet criteria for a specific vasculitic syndrome, his symptoms and blood test abnormalities were concerning for such a process. MELAS was included in our differential diagnosis because his symptoms failed to fit a defined vasculitic process. When genetic testing documented the presence of the point mutation A3243G, his diagnosis was changed. This case illustrates the importance of considering a mitochondrial genetic disorder in the differential diagnosis of patients who present to Rheumatologists with suspected unusual or atypical vasculitic symptoms.
Insights
Mitochondrial encephalomyopathy, lactic acidosis, and stroke (MELAS) is a genetic disorder. A case highlights MELAS as a crucial differential diagnosis for atypical vasculitic symptoms, emphasizing genetic testing for accurate diagnosis.
Area of Science:
- Neurology
- Genetics
- Rheumatology
Background:
- Mitochondrial encephalomyopathy, lactic acidosis, and stroke (MELAS) is a genetic disorder caused by the A3243G mutation.
- It presents with multisystemic symptoms including stroke-like episodes, encephalopathy, and lactic acidosis, typically in early adulthood.
Observation:
- A 26-year-old male presented with severe constipation due to intestinal dysmotility, initially suspected as primary central nervous system vasculitis.
- His symptoms were atypical for vasculitis, prompting consideration of other diagnoses.
Findings:
- Genetic testing revealed the characteristic A3243G point mutation, confirming a diagnosis of MELAS.
- The patient's presentation underscores the variability of MELAS manifestations.
Implications:
- This case emphasizes the importance of including mitochondrial genetic disorders like MELAS in the differential diagnosis for rheumatology patients with unusual vasculitic symptoms.
- Early and accurate diagnosis of MELAS is crucial for appropriate management and patient outcomes.
Related Concept Videos
Cytotoxic Edema: Pathophysiology
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Myocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Hypersensitivity Reactions: Immune-Complex Reactions
Vascular Spasm
